John Wagstaff
Swansea University
H-index: 60
Europe-United Kingdom
Top articles of John Wagstaff
Improved disease-free survival with adjuvant chemotherapy after nephroureterectomy for upper tract urothelial cancer: Final results of the POUT trial
Journal of Clinical Oncology
2024/2
Durable clinical outcomes in patients (pts) with advanced melanoma and progression-free survival (PFS)≥ 3y on nivolumab (NIVO)±ipilimumab (IPI) or IPI in checkmate 067.
2023/6/1
Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two …
The Lancet Oncology
2023/5/1
Gerhardt Attard
H-Index: 54
Laura Murphy
H-Index: 2
Ashwin Sachdeva
H-Index: 15
William Cross
H-Index: 7
Claire Murphy
H-Index: 1
John Wagstaff
H-Index: 32
James Wylie
H-Index: 2
Michael D Brown
H-Index: 4
David Matheson
H-Index: 16
Matthew R Sydes
H-Index: 54
Anil Kumar
H-Index: 20
Duncan Mclaren
H-Index: 16
Henry Taylor
H-Index: 8
John Graham
H-Index: 6
Paul Rogers
H-Index: 7
Simon Crabb
H-Index: 30
Ahmed Shaheen
H-Index: 1
Omar Khan
H-Index: 6
Andrew Chan
H-Index: 15
Imtiaz Ahmed
H-Index: 13
Cytoreductive nephrectomy and exposure to sunitinib – a post hoc analysis of the Immediate Surgery or Surgery After Sunitinib Malate in Treating Patients With …
BJU international
2022/7
Long-term survival in advanced melanoma for patients treated with nivolumab plus ipilimumab in CheckMate 067.
2022/6/1
Quality of life in men with prostate cancer randomly allocated to receive docetaxel or abiraterone in the STAMPEDE trial
Journal of clinical oncology: official journal of the American Society of Clinical Oncology
2022/3/3
Sports Traumatology
Arthroscopy: official journal of the ESSKA
2022
Long-term outcomes with nivolumab plus ipilimumab or nivolumab alone versus ipilimumab in patients with advanced melanoma
Journal for immunotherapy of cancer
2022
Survie à long terme chez les patients avec un mélanome avancé traités par NIVO et IPI dans l’étude CheckMate 067
Annales de Dermatologie et de Vénéréologie-FMC
2022/11/1
Docetaxel for nonmetastatic prostate cancer: long-term survival outcomes in the STAMPEDE randomized controlled trial
JNCI cancer spectrum
2022/8/1
Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised …
The lancet
2022/1/29
Gerhardt Attard
H-Index: 54
Laura Murphy
H-Index: 2
William Cross
H-Index: 7
John Wagstaff
H-Index: 32
James Wylie
H-Index: 2
David Matheson
H-Index: 16
Matthew R Sydes
H-Index: 54
Anil Kumar
H-Index: 20
Duncan Mclaren
H-Index: 16
Henry Taylor
H-Index: 8
John Graham
H-Index: 6
Paul Rogers
H-Index: 7
Simon Crabb
H-Index: 30
Ahmed Shaheen
H-Index: 1
Omar Khan
H-Index: 6
Andrew Chan
H-Index: 15
Imtiaz Ahmed
H-Index: 13
Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5‐year follow‐up results from the STAMPEDE randomised trial (NCT00268476)
International Journal of Cancer
2022/8/1
Étude CheckMate 067: résultats à 6, 5 ans chez des patients atteints d’un mélanome avancé
Annales de Dermatologie et de Vénéréologie-FMC
2021/12/1
CheckMate 067: 6.5-year outcomes in patients (pts) with advanced melanoma.
2021/5/20
Piotr Rutkowski
H-Index: 2
John Wagstaff
H-Index: 32
Updated outcomes of POUT: A phase III randomized trial of peri-operative chemotherapy versus surveillance in upper tract urothelial cancer (UTUC).
2021/2/20
Nivolumab versus everolimus in patients with advanced renal cell carcinoma: updated results with long‐term follow‐up of the randomized, open‐label, phase 3 CheckMate 025 trial
Cancer
2020/9/15
1082MO 5-year characterization of complete responses in patients with advanced melanoma who received nivolumab plus ipilimumab (NIVO+ IPI) or NIVO alone
Annals of Oncology
2020/9/1
Epstein-Barr virus-positive mucocutaneous ulcers complicate colitis caused by immune checkpoint regulator therapy and associate with colon perforation
Clinical Gastroenterology and Hepatology
2020/7/1
John Wagstaff
H-Index: 32
Dean Harris
H-Index: 11
CheckMate 067: Long-term outcomes in patients with mucosal melanoma.
2020/5/20
John Wagstaff
H-Index: 32
Editorial comment: comparison of immediate vs deferred cytoreductive nephrectomy in patients with synchronous metastatic renal cell carcinoma receiving sunitinib: the SURTIME …
International Brazilian Journal of Urology: official journal of the Brazilian Society of Urology
2020/5
Co-Authors
